산전 검사 및 신생아 스크리닝 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global prenatal testing & newborn screening market size is expected to reach USD 28.40 Billion in 2034 from USD 10.81 Billion in 2025, growing at a CAGR of 11.33 during 2026-2034.This market is witnessing strong growth as healthcare providers increasingly emphasize early diagnosis of genetic disorders and congenital conditions. Prenatal testing and newborn screening enable timely medical intervention, improving treatment outcomes and reducing long-term healthcare costs. Rising awareness regarding maternal and infant health, increasing birth rates in developing regions, and continuous advancements in diagnostic technologies are driving market expansion globally.

Growing adoption of non-invasive prenatal testing, molecular diagnostics, and advanced screening techniques has significantly improved diagnostic accuracy and patient safety. Governments are expanding newborn screening programs to identify inherited disorders at an early stage, while healthcare institutions continue investing in advanced laboratory infrastructure. Increasing healthcare expenditure and supportive public health initiatives are further strengthening market growth.

The future outlook for the prenatal testing and newborn screening market remains highly favorable as personalized medicine and genomic technologies continue advancing. Artificial intelligence-assisted diagnostics, next-generation sequencing, and improved biomarker discovery will enhance screening capabilities. Expanding healthcare access, rising investments in maternal healthcare, and increasing awareness of preventive diagnostics will generate significant growth opportunities worldwide.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Instruments
• Reagents
• Assay Kits
• Others

By Diagnosing Technique

• Non Invasive
• Invasive

By Screening Option

• First Trimester
• Second Trimester

By Technology

• Tandem Mass Spectrometry
• Electrophoresis
• Enzymes & Immuno Assays
• DNA Based Assays
• Pulse Oximetry Technology
• Hearing Screen Technology

COMPANIES PROFILED

• Natera, Inc., PerkinElmer, Inc., Illumina, Inc., Laboratory Corporation of America Holdings (Labcorp), Invitae Corporation, Centogene N.V., F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Baebies, Inc., Ravgen Inc., Eurofins Scientific SE, QIAGEN, Veracyte, Inc., NIPD Genetics, BGI Group, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY DIAGNOSING TECHNIQUE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Diagnosing Technique
• 5.2. Non Invasive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Invasive Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY SCREENING OPTION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Screening Option
• 6.2. First Trimester Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Second Trimester Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Technology
• 7.2. Tandem Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Enzymes & Immuno Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. DNA Based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Pulse Oximetry Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Hearing Screen Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Diagnosing Technique
  • 8.2.3 By Screening Option
  • 8.2.4 By Technology
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Diagnosing Technique
  • 8.3.3 By Screening Option
  • 8.3.4 By Technology
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Diagnosing Technique
  • 8.4.3 By Screening Option
  • 8.4.4 By Technology
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Diagnosing Technique
  • 8.5.3 By Screening Option
  • 8.5.4 By Technology
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Diagnosing Technique
  • 8.6.3 By Screening Option
  • 8.6.4 By Technology
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PRENATAL TESTING & NEWBORN SCREENING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 NateraInc
  • 10.2.2 PerkinElmerInc
  • 10.2.3 IlluminaInc
  • 10.2.4 Laboratory Corporation Of America Holdings (Labcorp)
  • 10.2.5 Invitae Corporation
  • 10.2.6 Centogene N.V
  • 10.2.7 F. Hoffmann-La Roche Ltd
  • 10.2.8 Quest Diagnostics Incorporated
  • 10.2.9 BaebiesInc
  • 10.2.10 Ravgen Inc
  • 10.2.11 Eurofins Scientific SE
  • 10.2.12 QIAGEN
  • 10.2.13 VeracyteInc
  • 10.2.14 NIPD Genetics
  • 10.2.15 BGI Group
  • 10.2.16 Bio-Rad LaboratoriesInc
  • 10.2.17 Thermo Fisher Scientific Inc